HAMPTON ROADS, Va. - Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults and is twice as common in men as in women. Nearly a third of patients won’t be diagnosed until cancer reaches advanced stages. Fortunately, research continues to progress and those affected by this disease may have a reason to feel more optimistic about available treatments. A new combination treatment is now available for newly-diagnosed patients with kidney cancer that has spread. Dr. Elizabeth Kessler joins us to discuss the importance of this first-line treatment option for advanced kidney cancer patients and Bryan Lewis of KidneyCAN will share insights on the experiences of people living with advanced kidney cancer.
For more information visit www.opdivo.com and kidneycan.org.
